Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cucchetti

Showing results (241-250 of 301) with videos related to

Pageof 31
Sort By:
Journal of Hepatology|October 12, 2007
Influence of steroids on HCV recurrence after liver transplantation: A prospective studyMarco Vivarelli, Patrizia Burra, Giuliano La Barba, et al.
Cancer|August 13, 2015
Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma?Gaya Spolverato, Alessandro Vitale, Alessandro Cucchetti, et al.
Journal of Hepatology|January 17, 2012
Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer populationAlessandro Cucchetti, Franco Trevisani, Matteo Cescon, et al.
Clinical Transplantation|June 20, 2009
Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumabTakuya Kimura, Augusto Lauro, Matteo Cescon, et al.
Transplantation|April 12, 2011
Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: a European multicentric case-control studyRoberto Ballarin, Alessandro Cucchetti, Mario Spaggiari, et al.
Hepato-Gastroenterology|December 24, 2008
A new liver transplant priority for patients with hepatocellular carcinomaMatteo Ravaioli, Gian Luca Grazi, Gaetano Vetrone, et al.
Medicine|June 3, 2020
Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenibAndrea Casadei-Gardini, Vincenzo Dadduzio, Giulia Rovesti, et al.
Annals of Hepatology|May 27, 2020
Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population?Francesco Giuseppe Foschi, Marco Domenicali, Pierluigi Giacomoni, et al.
Liver Cancer|June 23, 2025
Probability of Lymph Node Metastases in Patients Undergoing Adequate Lymphadenectomy during Surgery for Intrahepatic Cholangiocarcinoma: A Retrospective Multicenter StudyCarlo Sposito, Alessandro Cucchetti, Francesca Ratti, et al.
Scientific Reports|September 14, 2017
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantationMatteo Ravaioli, Alessandro Cucchetti, Antonio Daniele Pinna, et al.
Pageof 31

Showing results (241-250 of 301) with videos related to

Sort By:
Pageof 31
Journal of Hepatology|October 12, 2007
Influence of steroids on HCV recurrence after liver transplantation: A prospective studyMarco Vivarelli, Patrizia Burra, Giuliano La Barba, et al.
Cancer|August 13, 2015
Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma?Gaya Spolverato, Alessandro Vitale, Alessandro Cucchetti, et al.
Journal of Hepatology|January 17, 2012
Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer populationAlessandro Cucchetti, Franco Trevisani, Matteo Cescon, et al.
Clinical Transplantation|June 20, 2009
Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumabTakuya Kimura, Augusto Lauro, Matteo Cescon, et al.
Transplantation|April 12, 2011
Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: a European multicentric case-control studyRoberto Ballarin, Alessandro Cucchetti, Mario Spaggiari, et al.
Hepato-Gastroenterology|December 24, 2008
A new liver transplant priority for patients with hepatocellular carcinomaMatteo Ravaioli, Gian Luca Grazi, Gaetano Vetrone, et al.
Medicine|June 3, 2020
Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenibAndrea Casadei-Gardini, Vincenzo Dadduzio, Giulia Rovesti, et al.
Annals of Hepatology|May 27, 2020
Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population?Francesco Giuseppe Foschi, Marco Domenicali, Pierluigi Giacomoni, et al.
Liver Cancer|June 23, 2025
Probability of Lymph Node Metastases in Patients Undergoing Adequate Lymphadenectomy during Surgery for Intrahepatic Cholangiocarcinoma: A Retrospective Multicenter StudyCarlo Sposito, Alessandro Cucchetti, Francesca Ratti, et al.
Scientific Reports|September 14, 2017
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantationMatteo Ravaioli, Alessandro Cucchetti, Antonio Daniele Pinna, et al.
Pageof 31